Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera in Chronic Renal Anemia with Diabetic Nephropathy
NCT01191983Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2010
- Primary completion
- Apr 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Aug 2010; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01191983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01191983.